GlassScriptPhysician profile
Devin O'Hara
NPI 1962934349
$1,085.80
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $390 · 2023: $369 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $256.44 | 2022-2024 | Belbuca, Belbuca, Xtampza |
| Nevro Corp. | $235.27 | 2021-2023 | Senza |
| Boston Scientific Corporation | $144.82 | 2022 | |
| Mml US, INC. | $98.69 | 2023 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $75.96 | 2022-2024 | Ztlido |
| Valinor Pharma, LLC | $67.85 | 2023-2024 | Movantik |
| Relievant Medsystems, INC. | $51.88 | 2023 | Intracept |
| Medtronic, INC. | $32.17 | 2021-2022 | |
| Horizon Therapeutics Plc | $29.76 | 2022 | |
| Stimwave Technologies Incorporated | $23.14 | 2022 | |
| Abbott Laboratories | $22.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.61 | 2024 | Relistor |
| Amneal Pharmaceuticals LLC | $15.56 | 2022 | |
| Bioventus LLC | $13.16 | 2023 | Gelsyn-3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin O'Hara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.